Cross-talk between bile acids and gastrointestinal tract for progression and development of cancer and its therapeutic implications

IUBMB Life

Volumn 67, Issue 7, 2015, Pages 514-523

  Kundu, Somanath ^a,b   Kumar, Sandeep ^a,b   Bajaj, Avinash ^a  

^a REGIONAL CENTRE FOR BIOTECHNOLOGY   (India)

^b MANIPAL UNIVERSITY   (India)

Author keywords

bile acids; cancer therapeutics; colon cancer; gastrointestinal cancer

Indexed keywords

BILE ACID; CELL NUCLEUS RECEPTOR; FORMYLPEPTIDE RECEPTOR; MEMBRANE RECEPTOR; CELL RECEPTOR;

APOPTOSIS; BILE ACID SYNTHESIS; CANCER GROWTH; CANCER INCIDENCE; CANCER THERAPY; CELL DIFFERENTIATION; CELL RENEWAL; DIGESTIVE SYSTEM CANCER; DISEASE COURSE; ENTEROHEPATIC CIRCULATION; GASTROINTESTINAL TRACT; HUMAN; LIPID ABSORPTION; NONHUMAN; PASSIVE TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; STEREOCHEMISTRY; CHEMISTRY; DRUG EFFECTS; GASTROINTESTINAL NEOPLASMS; METABOLISM; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

APOPTOSIS; BILE ACIDS AND SALTS; BIOLOGICAL TRANSPORT; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL TRACT; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION;

EID: 84937970200     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1399     Document Type: Review

References (70)

1. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., et al., (2011) Global cancer statistics. CA Cancer J. Clin. 61, 69-90.
2. Chao, A., Thun, M. J., Connell, C. J., McCullough, M. L., Jacobs, E. J., et al., (2005) Meat consumption and risk of colorectal cancer. JAMA 293, 172-182.
3. Carroll, K. K., (1991) Dietary fats and cancer. Am. J. Clin. Nutr. 53, 1064-1067.
4. Cross, A. J., Leitzmann, M. F., Gail, M. H., Hollenbeck, A. R., Schatzkin, A., et al., (2007) Prospective study of red and processed meat intake in relation to cancer risk. PLoS Med. 4, e325.
5. Reddy, B. S., and, Wynder, E. L., (1977) Metabolic epidemiology of colon cancer. Fecal bile acids and neutral sterols in colon cancer patients and patient are with adenomatous polyps. Cancer 39, 2533-2539.
6. Bernstein, C., Holubec, H., Bhattacharyya, A. K., Nguyen, H., Payne, C. M., et al., (2011) Carcinogenicity of deoxycholate, a secondary bile acid. Arch. Toxicol. 85, 863-871.
7. Monte, M. J., Marin, J. J., Antelo, A., and, Vazquez-Tato, J., (2009) Bile acids: chemistry, physiology, and pathophysiology. World J. Gastroenterol. 15, 804-816.
8. Mukhopadhyay, S., and, Maitra, U., (2004) Chemistry and biology of bile acids. Curr. Sci. 87, 1666-1683.
9. Hofmann, A. F., and, Hagey, L. R., (2008) Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell. Mol. Life Sci. 65, 2461-2483.
10. Russell, D. W., (2003) The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 72, 137-174.
11. Ridlon, J. M., Kang, D. J., and, Hylemon, P. B., (2006) Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 47, 241-259.
12. Degirolamo, C., Modica, S., Palasciano, G., and, Moschetta, A., (2011) Bile acids and colon cancer: solving the puzzle with nuclear receptors. Trends Mol. Med. 17, 564-572.
13. Hofmann, A. F., (2009) The enterohepatic circulation of bile acids in mammals: form and functions. Front. Biosci. 14, 2584-2598.
14. Chiang, J. Y., (2009) Bile acids: regulation of synthesis. J. Lipid Res. 50, 1955-1966.
15. Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., and, Learned, R. M., (1999) Identification of a nuclear receptor for bile acids. Science 284, 1362-1365.
16. Wang, H., Chen, J., Hollister, K., Sowers, L. C., and, Forman, B. M., (1999) Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell. 3, 543-553.
17. Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., et al., (1999) Bile acids: natural ligands for an orphan nuclear receptor. Science 284, 1365-1368.
18. Chiang, J. Y., Kimmel, R., Weinberger, C., and, Stroup, D., (2000) Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription. J. Biol. Chem. 275, 10918-10924.
19. Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., et al., (2005) Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2, 217-225.
20. Dawson, P. A., Hubbert, M., Haywood, J., Craddock, A. L., Zerangue, N,., et al. (2005) The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter. J. Biol. Chem. 280, 6960-6968.
21. Ballatori, N., Christian, W. V., Lee, J. Y., Dawson, P. A., Soroka, C. J., et al., (2005) OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia. Hepatology 42, 1270-1279.
22. Inagaki, T., Moschetta, A., Lee, Y. K., Peng, L., Zhao, G., et al., (2006) Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc. Natl. Acad. Sci. USA 103, 3920-3925.
23. Kim, I., Morimura, K., Shah, Y., Yang, Q., Ward, J. M., et al., (2007) Spontaneous hepato carcinogenesis in Farnesoid X receptor-null mice. Carcinogenesis 28, 940-946.
24. Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., et al., (2002) Vitamin D receptor as an intestinal bile acid sensor. Science 296, 1313-1316.
25. Newmark, H. L., Yang, K., Kurihara, N., Fan, K., Augenlicht, L. H., et al., (2009) Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer. Carcinogenesis 30, 88-92.
26. Hofmann, A. F., (2004) Detoxification of lithocholic acid, a toxic bile acid: relevance to drug hepatotoxicity. Drug Metab. Rev. 36, 703-722.
27. Owen, B. M., Milona, A., van Mil, S., Clements, P., Holder, J., et al., (2010) Intestinal detoxification limits the activation of hepatic Pregnane X receptor by lithocholic acid. Drug Metab. Dispos. 38, 143-149.
28. Zhou, J., Liu, M., Zhai, Y., and, Xie, W., (2008) The antiapoptotic role of Pregnane X receptor in human colon cancer cells. Mol. Endocrinol. 22, 868-880.
29. Saini, S. P., Sonoda, J., Xu, L., Toma, D., Uppal, H., et al., (2004) A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification. Mol. Pharmacol. 65, 292-300.
30. Chang, T. K., (2009) Activation of Pregnane X receptor (PXR) and constitutive androstane receptor (CAR) by herbal medicines. AAPS J. 11, 590-601.
31. Uppal, H., Toma, D., Saini, S. P., Ren, S., Jones, T. J., et al., (2005) Combined loss of orphan receptors PXR and CAR heightens sensitivity to toxic bile acids in mice. Hepatology 41, 168-176.
32. Beilke, L. D., Aleksunes, L. M., Holland, R. D., Besselsen, D. G., Beger, R. D., et al., (2009) Constitutive androstane receptor-mediated changes in bile acid composition contributes to hepatoprotection from lithocholic acid-induced liver injury in mice. Drug Metab. Dispos. 37, 1035-1045.
33. Maruyama, T., Miyamoto, Y., Nakamura, T., Tamai, Y., Okada, H., et al., (2002) Identification of membrane-type receptor for bile acids (M-BAR). Biochem. Biophys. Res. Commun. 298, 714-719.
34. Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., et al., (2006) Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439, 484-489.
35. Ferrari, C., Macchiarulo, A., Costantino, G., and, Pellicciari, R., (2006) Pharmacophore model for bile acids recognition by the FPR receptor. J. Comput. Aided Mol. Des. 20, 295-303.
36. Chen, X., Yang, D., Shen, W., Dong, H. F., Wang, J. M., et al., (2000) Characterization of chenodeoxycholic acid as an endogenous antagonist of the G-coupled formyl peptide receptors. Inflamm. Res. 49, 744-755.
37. Wess, J., Eglen, R. M., and, Gautam, D., (2007) Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat. Rev. Drug Discov. 6, 721-733.
38. Raufman, J. P., Zimniak, P., and, Bartoszko-Malik, A., (1998) Lithocholyltaurine interacts with cholinergic receptors on dispersed chief cells from Guinea pig stomach. Am. J. Physiol. 274, 997-1004.
39. Jean-Louis, S., Akare, S., Ali, M. A., Mash, E. A. Jr., Meuillet, E., et al., (2006) Deoxycholic acid induces intracellular signaling through membrane perturbations. J. Biol. Chem. 281, 14948-14960.
40. Kyriakis, J. M., and, Avruch, J., (2012) Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol. Rev. 92, 689-737.
41. Zeng, H., Botnen, J. H., and, Briske-Anderson, M., (2010) Deoxycholic acid and selenium metabolite methylselenol exert common and distinct effects on cell cycle, apoptosis, and MAP kinase pathway in HCT116 human colon cancer cells. Nutr. Cancer 62, 85-92.
42. Cheng, K., and, Raufman, J. P., (2005) Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors. Biochem. Pharmacol. 70, 1035-1047.
43. Pai, R., Tarnawski, A. S., and, Tran, T., (2004) Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness. Mol. Biol. Cell. 15, 2156-2163.
44. Huo, X., Juergens, S., Zhang, X., Rezaei, D., Yu, C., et al., (2011) Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 301, 278-286.
45. Kim, D.-H., and, Lee., J. W., (2011) Tumor suppressor p53 regulates bile acid homeostasis via small heterodimer partner. Proc. Natl. Acad. Sci. USA 108, 12266-12270.
46. Vogel, S. M., Bauer, M. R., Joerger, A. C., Wilcken, R., Brandt, T., et al., (2012) Lithocholic acid is an endogenous inhibitor of MDM4 and MDM2. Proc. Natl. Acad. Sci. USA 109, 16906-16910.
47. Qiao, D., Gaitonde, S. V., Qi, W., and, Martinez, J. D., (2001) Deoxycholic acid suppresses p53 by stimulating proteasome-mediated p53 protein degradation. Carcinogenesis 22, 957-964.
48. Wang, X., Zhou, P., Sun, X., Zheng, J., Wei, G., et al., (2015) Acidified bile acids increase hTERT expression via c-myc activation in human gastric cancer cells. Oncol Rep. 33, 3038-3044.
49. Berg, A., (1973) Nutrition, development, and population growth. Popul. Bull. 29, 3-37.
50. Bayerdorffer, E., Mannes, G. A., Ochsenkuhn, T., Dirschedl, P., Wiebecke, B., et al., (1995) Unconjugated bile acids in serum of patients with colorectal adenomas. Gut 36, 268-273.
51. Nagengast, F. M., Grubben, M. J., and, van Munster, I. P., (1995) Role of bile acids in colorectal carcinogenesis. Eur. J. Cancer A 31, 1067-1070.
52. Debruyne, P. R., Bruyneel, E. A., Li, X., Zimber, A., Gespach, C., et al., (2001) The role of bile acids in carcinogenesis. Mutat. Res. 480-481, 359-369.
53. Lozano, E., Sanchez-Vicente, L., Monte, M. J., Herraez, E., Briz, O., et al., (2014) Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development. Mol. Cancer Res. 12, 91-100.
54. Liu, R., Zhao, R., Zhou, X., Liang, X., Campbell, D. J., et al., (2014) Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2. Hepatology 60, 908-918.
55. Cai, J. S., and, Chen, J. H., (2014) The mechanism of enterohepatic circulation in the formation of gallstone disease. J. Membr. Biol. 247, 1067-1082.
56. Kapoor, V. K., and, McMichael, A. J., (2003) Gallbladder cancer: an 'Indian' disease. Natl. Med. J. India 16, 209-213.
57. Lowenfels, A. B., Walker, A. M., Althaus, D. P., Townsend, G., and, Domellof, L., (1989) Gallstone growth, size, and risk of gallbladder cancer: an interracial study. Int. J. Epidemiol. 18, 50-54.
58. Powell, A. A., LaRue, J. M., Batta, A. K., and, Martinez, J. D., (2001) Bile acid hydrophobicity is correlated with induction of apoptosis and/or growth arrest in HCT116 cells. Biochem. J. 356, 481-486.
59. Martinez, J. D., Stratagoules, E. D., LaRue, J. M., Powell, A. A., Gause, P. R., et al., (1998) Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation. Nutr. Cancer 31, 111-118.
60. Payne, C. M., Weber, C., Crowley-Skillicorn, C., Dvorak, K., Bernstein, H., et al., (2007) Deoxycholate induces mitochondrial oxidative stress and activates NF-kappaB through multiple mechanisms in HCT-116 colon epithelial cells. Carcinogenesis 28, 215-222.
61. Katona, B. W., Anant, S., Covey, D. F., and, Stenson, W. F., (2009) Characterization of enantiomeric bile acid-induced apoptosis in colon cancer cell lines. J. Biol. Chem. 284, 3354-3364.
62. Choi, Y. H., Im, E. O., Suh, H., Jin, Y., Yoo, Y. H., et al., (2003) Apoptosis and modulation of cell cycle control by synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid in human prostate cancer cells. Cancer Lett. 199, 157-167.
63. Im, E. O., Choi, Y. H., Paik, K. J., Suh, H., Jin, Y., et al., (2001) Novel bile acid derivatives induce apoptosis via a p53-independent pathway in human breast carcinoma cells. Cancer Lett. 163, 83-93.
64. Goldberg, A. A., Beach, A., Davies, G. F., Harkness, T. A., Leblanc, A., et al., (2011) Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells. Oncotarget 2, 761-782.
65. Goldberg, A. A., Titorenko, V. I., Beach, A., and, Sanderson, J. T., (2013) Bile acids induce apoptosis selectively in androgen-dependent and -independent prostate cancer cells. PeerJ. 1, e122
66. Singh, M., Singh, A., Kundu, S., Bansal, S., and, Bajaj, A., (2013) Deciphering the role of charge, hydration, and hydrophobicity for cytotoxic activities and membrane interactions of bile acid based facial amphiphiles. Biochim. Biophys. Acta 1828, 1926-1937.
67. Singh, M., Bansal, S., Kundu, S., Bhargava, P., Singh, A., et al., (2015) Synthesis, structure-activity relationship, and mechanistic investigation of lithocholic acid amphiphiles for colon cancer therapy. Med. Chem. Commun. 6, 192-201.
68. Adachi, R., Honma, Y., Masuno, H., Kawana, K., Shimomura, I., et al., (2015) Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative. J. Lipid Res. 46, 46-57.
69. Sreekanth, V., Bansal, S., Motiani, R., Kundu, S., Muppu, S. K., et al., (2013) Design, synthesis and mechanistic investigations of bile acid-tamoxifen conjugates for breast cancer therapy. Bioconjugate Chem. 24, 1468-1484.
70. Yadav, K., Bhargava, P., Bansal, S., Singh, M., Gupta, S., et al., (2015) Nature of the charged head group dictates the anticancer potential of lithocholic acid-tamoxifen conjugates for breast cancer therapy. Med. Chem. Commun. 6, 778-787.